Research graph
References from Cost-effectiveness of community-based artificial intelligence screening for retinopathy of prematurity. Local targets link to admitted publications; unresolved targets remain external evidence.
Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
10.1016/s0140-6736(24)00550-6 · 2024 · External reference
Global, Regional, and National Incidence and Mortality of Neonatal Preterm Birth, 1990-2019.
10.1001/jamapediatrics.2022.1622 · 2022 · External reference
Preterm births in China between 2012 and 2018: an observational study of more than 9 million women.
10.1016/s2214-109x(21)00298-9 · 2021 · External reference
Prevalence, Years Lived With Disability, and Time Trends for 16 Causes of Blindness and Vision Impairment: Findings Highlight Retinopathy of Prematurity.
10.3389/fped.2022.735335 · 2022 · External reference
A worldwide survey of retinopathy of prematurity screening.
10.1136/bjophthalmol-2017-310709 · 2018 · External reference
Global and Regional Trends in Retinopathy of Prematurity.
10.1001/jamaophthalmol.2025.5103 · 2026 · External reference
Identification of novel biomarkers for retinopathy of prematurity in preterm infants by use of innovative technologies and artificial intelligence.
10.1016/j.preteyeres.2023.101208 · 2023 · External reference
The prevalence of retinopathy of prematurity in the mainland of China from 2008 to 2018.
2021 · External reference
Artificial intelligence for the diagnosis of retinopathy of prematurity: A systematic review of current algorithms.
10.1038/s41433-022-02366-y · 2023 · External reference
Use of an Artificial Intelligence-Generated Vascular Severity Score Improved Plus Disease Diagnosis in Retinopathy of Prematurity.
10.1016/j.ophtha.2024.06.006 · 2024 · External reference
Epidemiologic Evaluation of Retinopathy of Prematurity Severity in a Large Telemedicine Program in India Using Artificial Intelligence.
10.1016/j.ophtha.2023.03.026 · 2023 · External reference
Efficacy of Smartphone-Based Telescreening for Retinopathy of Prematurity With and Without Artificial Intelligence in India.
10.1001/jamaophthalmol.2023.1466 · 2023 · External reference
AI-Enabled Screening for Retinopathy of Prematurity in Low-Resource Settings.
10.1001/jamanetworkopen.2025.7831 · 2025 · External reference
Cost-effectiveness of Artificial Intelligence-Based Retinopathy of Prematurity Screening.
10.1001/jamaophthalmol.2022.0223 · 2022 · External reference
A Systematic Review of Economic Evaluations Conducted for Interventions to Screen, Treat, and Manage Retinopathy of Prematurity (ROP) in the United States, United Kingdom, and Canada.
10.1080/09286586.2022.2084757 · 2023 · External reference
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force.
10.1016/j.jval.2021.10.008 · 2022 · External reference
Expert consensus on the classification and treatment of retinopathy of prematurity in China (2023 edition).
2023 · External reference
A cost-effectiveness analysis of newborn hearing screening strategies.
10.1001/archpedi.154.5.484 · 2000 · External reference
Cost-effectiveness of newborn screening for severe combined immunodeficiency.
10.1007/s00431-019-03346-3 · 2019 · External reference
Cost-Effectiveness of Newborn Screening for Phenylketonuria and Congenital Hypothyroidism.
10.1016/j.jpeds.2022.10.046 · 2023 · External reference
Unresolved reference
External reference
Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.
10.1001/archopht.121.12.1684 · 2003 · External reference
[Expert Consensus on Neonatal Fundus Screening].
2018 · External reference
Auckland regional telemedicine retinopathy of prematurity screening network: A 10-year review.
10.1111/ceo.13593 · 2019 · External reference
Early detection of ocular abnormalities in a Chinese multicentre neonatal eye screening programme-1-year result.
10.1111/aos.14586 · 2021 · External reference
Screening for retinopathy of prematurity in China: a five-year cohort study in seven screening centers.
10.1186/s12886-024-03836-5 · 2025 · External reference
A Cross-Sectional Nationwide Study on Accessibility and Availability of Neonatal care Resources in Hospitals of China: Current Situation, Mortality and Regional Differences: Neonatal Care Resources and Newborn Mortality in China.
2021 · External reference
[Status of the occurrence and screening of retinopathy of prematurity].
2022 · External reference
Cost-effectiveness and cost-utility of traditional and telemedicine combined population-based age-related macular degeneration and diabetic retinopathy screening in rural and urban China.
10.1016/j.lanwpc.2022.100435 · 2022 · External reference
[Effect of multidisciplinary health education in screening of retinopathy in premature infants].
2020 · External reference
Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model.
10.1016/s2214-109x(19)30201-3 · 2019 · External reference
[Incidence of retinopathy of prematurity among infants less than 34 weeks’ gestation before discharge in 25 NICUs in China: A cross-sectional survey].
2020 · External reference
Automated Explainable Multidimensional Deep Learning Platform of Retinal Images for Retinopathy of Prematurity Screening.
10.1001/jamanetworkopen.2021.8758 · 2021 · External reference
DeepQuality improves infant retinopathy screening.
10.1038/s41746-023-00943-3 · 2023 · External reference
Unresolved reference
External reference
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.
10.1001/jama.2016.12195 · 2016 · External reference
Health-related quality of life at age 10 years in very low-birth-weight children with and without threshold retinopathy of prematurity.
10.1001/archopht.122.11.1659 · 2004 · External reference
Cost-utility analysis of telemedicine and ophthalmoscopy for retinopathy of prematurity management.
10.1001/archopht.126.4.493 · 2008 · External reference
Long-term functional results following vitrectomy for advanced retinopathy of prematurity.
10.1136/bjophthalmol-2016-309198 · 2017 · External reference
Vision and quality-of-life.
1999 · External reference
Unresolved reference
External reference
Informing a Cost-Effectiveness Threshold for Health Technology Assessment in China: A Marginal Productivity Approach.
10.1007/s40273-020-00954-y · 2020 · External reference
Incidence of retinopathy of prematurity treatment in extremely preterm infants in China.
10.1111/ppe.12810 · 2022 · External reference
[Incidence trend of retinopathy of prematurity in Zhuhai]
2024 · External reference
The treatment and risk factors of retinopathy of prematurity in neonatal intensive care units.
10.1186/s12886-018-0973-1 · 2018 · External reference
Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis.
10.1016/s2214-109x(22)00554-x · 2023 · External reference
Cost-effectiveness of screening and cryotherapy for threshold retinopathy of prematurity.
10.1542/peds.91.5.859 · 1993 · External reference
The societal burden of blindness secondary to retinopathy of prematurity in Lima, Peru.
10.1016/j.ajo.2012.04.003 · 2012 · External reference
Health impact and economic evaluation of the Expanded Program on Immunization in China from 1974 to 2024: a modelling study.
10.1016/s2468-2667(25)00039-8 · 2025 · External reference
Cost-effectiveness and cost-utility of community-based blinding fundus diseases screening with artificial intelligence: A modelling study from Shanghai, China.
10.1016/j.compbiomed.2024.109329 · 2024 · External reference
Evaluating a Portable, Noncontact Fundus Camera for Retinopathy of Prematurity Screening by Nonophthalmologist Health Care Workers.
10.1016/j.oret.2017.12.003 · 2018 · External reference
Efficacy of Smartphone-Based Telescreening for Retinopathy of Prematurity With and Without Artificial Intelligence in India.
10.1001/jamaophthalmol.2023.1466 · 2023 · External reference
Advancing AMD screening with an offline, AI-powered smartphone-based fundus camera: A prospective, real-world clinical validation.
10.1038/s41433-025-03902-2 · 2025 · External reference
Revisiting Alma-Ata: what is the role of primary health care in achieving the Sustainable Development Goals?
10.1016/s0140-6736(18)31829-4 · 2018 · External reference
Quality of primary health care in China: challenges and recommendations.
10.1016/s0140-6736(20)30122-7 · 2020 · External reference
A systematic study on the prevention and treatment of retinopathy of prematurity in China.
10.1186/s12886-018-0708-3 · 2018 · External reference
Principles to guide clinical AI readiness and move from benchmarks to real-world evaluation.
10.1038/s41591-025-04198-1 · 2026 · External reference
